XmAb-942
- Generic Name
- XmAb-942
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- GALE Therapeutics Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT06619990
- Locations
- 🇦🇺
Linear Clinical Research, Nedlands, Western Australia, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath